Andreas Halvorsen: portfolio of Viking Global Investors
Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 7, 2020. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2020. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 23.1B USD
- Positions
- 72
- Share of the ten largest
- 44.3%
The ten largest positions Q2 2020
- Amazon 7.3%▼ −30.4%
- Adaptive Biotechnologies Cor 7.0%unchanged
- Comcast 4.8%▲ +59.3%
- Centene Corporation 4.4%▼ −0.8%
- American Express 4.3%▲ +170.7%
- Fidelity National Information Services 3.9%▲ +76.7%
- Bridgebio Pharma Inc 3.8%unchanged
- Microsoft 3.3%▼ −24.3%
- Boston Scientific 2.8%▼ −42.0%
- Thermo Fisher Scientific 2.7%new
Show all positions of this quarter
Choose a quarter (54 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
- Q1 2014
- Q4 2013
- Q3 2013
- Q2 2013
All positions Q2 2020
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 7.3% | 612,886 | 1.7B USD | −30.4% reduced | Q2 2015 21 quarters |
| NFLX Netflix | 0.7% | 356,549 | 162.2M USD | −86.6% reduced | Q3 2015 20 quarters |
| Editas Medicine Inc | < 0.1% | 413,000 | 12.2M USD | −19.4% reduced | Q1 2016 18 quarters |
| MSFT Microsoft | 3.3% | 3,710,674 | 755.2M USD | −24.3% reduced | Q2 2016 17 quarters |
| V Visa Inc. | 0.1% | 164,889 | 31.9M USD | −61.7% reduced | Q3 2016 16 quarters |
| Liberty Media Corp Del | 0.3% | 1,923,501 | 61.0M USD | unchanged | Q1 2017 14 quarters |
| Catalent Inc | 0.5% | 1,493,703 | 109.5M USD | −22.9% reduced | Q1 2018 10 quarters |
| CNC Centene Corporation | 4.4% | 16,106,578 | 1.0B USD | −0.8% reduced | Q2 2018 9 quarters |
| BSX Boston Scientific | 2.8% | 18,457,273 | 648.0M USD | −42.0% reduced | Q3 2018 8 quarters |
| AON Aon plc | 2.5% | 2,956,029 | 569.3M USD | +29.1% increased | Q3 2018 8 quarters |
| Exact Sciences Corp | 0.8% | 2,182,534 | 189.8M USD | −10.1% reduced | Q3 2018 8 quarters |
| Blueprint Medicines Corp | 0.5% | 1,629,716 | 127.1M USD | +1.8% increased | Q3 2018 8 quarters |
| JD JD.com (ADR) | 2.1% | 8,266,459 | 497.5M USD | −56.2% reduced | Q1 2019 6 quarters |
| MELI MercadoLibre | 0.3% | 69,344 | 68.4M USD | −82.2% reduced | Q1 2019 6 quarters |
| Adaptive Biotechnologies Cor | 7.0% | 33,493,708 | 1.6B USD | unchanged | Q2 2019 5 quarters |
| Bridgebio Pharma Inc | 3.8% | 26,620,991 | 868.1M USD | unchanged | Q2 2019 5 quarters |
| UBER Uber | 2.2% | 16,470,839 | 511.9M USD | −37.2% reduced | Q2 2019 5 quarters |
| CRM Salesforce | 1.7% | 2,145,463 | 401.9M USD | −38.8% reduced | Q2 2019 5 quarters |
| AIZ Assurant | 1.3% | 2,826,277 | 291.9M USD | +31.6% increased | Q2 2019 5 quarters |
| LOW Lowe's | 1.0% | 1,710,360 | 231.1M USD | −68.7% reduced | Q2 2019 5 quarters |
| Avantor Inc | 0.4% | 5,475,379 | 93.1M USD | −45.5% reduced | Q2 2019 5 quarters |
| FTV Fortive | 2.6% | 8,760,046 | 592.7M USD | −7.0% reduced | Q3 2019 4 quarters |
| Guardant Health Inc | 1.1% | 3,068,173 | 248.9M USD | −19.2% reduced | Q3 2019 4 quarters |
| Molina Healthcare Inc | 0.8% | 1,013,668 | 180.4M USD | −25.8% reduced | Q3 2019 4 quarters |
| Genmab A/S | < 0.1% | 575,086 | 19.5M USD | −31.6% reduced | Q3 2019 4 quarters |
| Atyr Pharma Inc | < 0.1% | 587,444 | 2.6M USD | unchanged | Q3 2019 4 quarters |
| CMCSA Comcast | 4.8% | 28,523,676 | 1.1B USD | +59.3% increased | Q4 2019 3 quarters |
| FIS Fidelity National Information Services | 3.9% | 6,714,021 | 900.3M USD | +76.7% increased | Q4 2019 3 quarters |
| CI Cigna | 2.4% | 2,949,644 | 553.5M USD | +15.8% increased | Q4 2019 3 quarters |
| BKNG Booking Holdings | 1.4% | 202,747 | 322.8M USD | +8.5% increased | Q4 2019 3 quarters |
| Anaplan Inc | 1.1% | 5,746,829 | 260.4M USD | +4,823.5% increased | Q4 2019 3 quarters |
| SE Sea Limited (ADR) | 0.8% | 1,727,380 | 185.2M USD | +30.5% increased | Q4 2019 3 quarters |
| Bristol-Myers Squibb Co | 0.3% | 18,968,019 | 67.9M USD | −3.4% reduced | Q4 2019 3 quarters |
| Viela Bio Inc | 0.2% | 1,049,000 | 45.4M USD | −16.1% reduced | Q4 2019 3 quarters |
| AXP American Express | 4.3% | 10,497,498 | 999.4M USD | +170.7% increased | Q1 2020 2 quarters |
| JPM JPMorgan Chase | 2.6% | 6,411,486 | 603.1M USD | +56.9% increased | Q1 2020 2 quarters |
| LVS Las Vegas Sands | 2.2% | 11,125,343 | 506.6M USD | +259.5% increased | Q1 2020 2 quarters |
| TMUS T-Mobile US | 1.7% | 3,799,550 | 395.7M USD | +203.0% increased | Q1 2020 2 quarters |
| IR Ingersoll Rand | 1.2% | 10,196,427 | 286.7M USD | −15.1% reduced | Q1 2020 2 quarters |
| WDAY Workday, Inc. | 1.2% | 1,490,882 | 279.3M USD | −39.4% reduced | Q1 2020 2 quarters |
| CB Chubb Limited | 1.2% | 2,202,033 | 278.8M USD | +139.7% increased | Q1 2020 2 quarters |
| MU Micron Technology | 0.8% | 3,392,745 | 174.8M USD | −49.5% reduced | Q1 2020 2 quarters |
| Encompass Health Corp | 0.7% | 2,677,612 | 165.8M USD | +85.2% increased | Q1 2020 2 quarters |
| COO Cooper Companies (The) | 0.4% | 345,523 | 98.0M USD | −20.9% reduced | Q1 2020 2 quarters |
| Horizon Therapeutics Pub Ltd | 0.4% | 1,471,419 | 81.8M USD | −26.1% reduced | Q1 2020 2 quarters |
| CME CME Group | 0.3% | 482,679 | 78.5M USD | −71.6% reduced | Q1 2020 2 quarters |
| Change Healthcare Inc | 0.2% | 4,326,999 | 48.5M USD | −66.1% reduced | Q1 2020 2 quarters |
| Varian Med Sys Inc | 0.2% | 365,827 | 44.8M USD | −57.8% reduced | Q1 2020 2 quarters |
| TMO Thermo Fisher Scientific | 2.7% | 1,734,144 | 628.4M USD | new | Q2 2020 1 quarter |
| HLT Hilton Worldwide | 2.3% | 7,272,455 | 534.2M USD | new | Q2 2020 1 quarter |
| Api Group Corp | 1.8% | 33,333,333 | 405.0M USD | new | Q2 2020 1 quarter |
| Nuance Communications Inc | 1.4% | 12,799,556 | 323.9M USD | new | Q2 2020 1 quarter |
| MCO Moody's Corporation | 1.2% | 977,348 | 268.5M USD | new | Q2 2020 1 quarter |
| PH Parker Hannifin | 1.1% | 1,442,793 | 264.4M USD | new | Q2 2020 1 quarter |
| ADI Analog Devices | 1.0% | 1,959,943 | 240.4M USD | new | Q2 2020 1 quarter |
| SHW Sherwin-Williams | 1.0% | 397,835 | 229.9M USD | new | Q2 2020 1 quarter |
| DRI Darden Restaurants | 1.0% | 2,991,636 | 226.7M USD | new | Q2 2020 1 quarter |
| Zentalis Pharmaceuticals Inc | 0.9% | 4,443,284 | 213.4M USD | new | Q2 2020 1 quarter |
| ALL Allstate | 0.7% | 1,769,570 | 171.6M USD | new | Q2 2020 1 quarter |
| LIN Linde plc | 0.7% | 803,694 | 170.5M USD | new | Q2 2020 1 quarter |
| DHR Danaher Corporation | 0.7% | 903,929 | 159.8M USD | new | Q2 2020 1 quarter |
| BABA Alibaba Group (ADR) | 0.6% | 695,536 | 150.0M USD | new | Q2 2020 1 quarter |
| ALGN Align Technology | 0.6% | 539,343 | 148.0M USD | new | Q2 2020 1 quarter |
| Royalty Pharma PLC | 0.5% | 2,514,985 | 122.1M USD | new | Q2 2020 1 quarter |
| Envista Holdings Corporation | 0.4% | 4,524,346 | 95.4M USD | new | Q2 2020 1 quarter |
| EG Everest Group | 0.4% | 418,223 | 86.2M USD | new | Q2 2020 1 quarter |
| TJX TJX Companies | 0.3% | 1,519,986 | 76.9M USD | new | Q2 2020 1 quarter |
| Pvh Corporation | 0.3% | 1,522,984 | 73.2M USD | new | Q2 2020 1 quarter |
| Momenta Pharmaceuticals Inc | 0.1% | 946,220 | 31.5M USD | new | Q2 2020 1 quarter |
| Agora Inc | < 0.1% | 400,000 | 17.7M USD | new | Q2 2020 1 quarter |
| Uniqure NV | < 0.1% | 62,396 | 2.8M USD | new | Q2 2020 1 quarter |
| T-Mobile US Inc | < 0.1% | 1,799,550 | 302.0K USD | new | Q2 2020 1 quarter |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Breakdown by sector
- Financials 18.5%
- Consumer Discretionary 15.5%
- Health Care 14.1%
- Technology 8.0%
- Communication Services 7.2%
- Industrials 7.2%
- Materials 1.7%
- not in our coverage 27.8%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors